EDOLYNX Trademark

Trademark Overview

On Saturday, November 4, 2017, a trademark application was filed for EDOLYNX with the United States Patent and Trademark Office. The USPTO has given the EDOLYNX trademark a serial number of 87672136. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 18, 2021. This trademark is owned by Glaxo Group Limited. The EDOLYNX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
edolynx

General Information

Serial Number87672136
Word MarkEDOLYNX
Filing DateSaturday, November 4, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 18, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 17, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 14, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, October 18, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 18, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 9, 2021EXTENSION 5 GRANTED
Tuesday, February 2, 2021EXTENSION 5 FILED
Monday, March 8, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 17, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 2, 2021TEAS EXTENSION RECEIVED
Friday, August 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 12, 2020EXTENSION 4 GRANTED
Wednesday, August 12, 2020EXTENSION 4 FILED
Wednesday, August 12, 2020TEAS EXTENSION RECEIVED
Thursday, January 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 28, 2020EXTENSION 3 GRANTED
Tuesday, January 28, 2020EXTENSION 3 FILED
Tuesday, January 28, 2020TEAS EXTENSION RECEIVED
Tuesday, September 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 6, 2019EXTENSION 2 GRANTED
Friday, September 6, 2019EXTENSION 2 FILED
Friday, September 6, 2019TEAS EXTENSION RECEIVED
Tuesday, March 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 8, 2019EXTENSION 1 GRANTED
Friday, March 8, 2019EXTENSION 1 FILED
Friday, March 8, 2019TEAS EXTENSION RECEIVED
Tuesday, September 11, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 17, 2018PUBLISHED FOR OPPOSITION
Wednesday, June 27, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 11, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 24, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 24, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 24, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 7, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 7, 2017NON-FINAL ACTION E-MAILED
Thursday, December 7, 2017NON-FINAL ACTION WRITTEN
Wednesday, December 6, 2017ASSIGNED TO EXAMINER
Tuesday, November 14, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, November 8, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

edolynx pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological